Sleep-disordered breathing and pregnancy: Potential mechanisms and evidence for maternal and fetal morbidity

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 6, 2010, Pages 574-582

  Izci Balserak, Bilgay ^a   Pien, Grace W ^a,b  

^a Center for Sleep and Respiratory Neurobiology   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Gestational diabetes; gestational hypertension; preeclampsia; sleep apnea; sleepdisordered breathing

Indexed keywords

ADIPOCYTOKINE;

GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MATERNAL HYPERTENSION; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; REVIEW; SLEEP DISORDERED BREATHING; SLEEP TIME; SNORING; SYMPATHETIC TONE;

DIABETES, GESTATIONAL; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS; SLEEP APNEA SYNDROMES; SNORING;

EID: 77958152495     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32833f0d55     Document Type: Review

References (120)

1. Izci B, Lee K. Sleep disturbances during pregnancy. In: Kryger M, Roth T, Dement W, editors. Principles and practice of sleep medicine. 5th (forthcoming) ed. Philadelphia: Saunders; 2010.
2. Maski KP, Kothare SV. Searching for marker of REM sleep behavior disorder: submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy. Sleep 2009; 32:137.
3. Arnardottir ES, Mackiewicz M, Gislason T, et al. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009; 32:447-470.
4. Izci-Balserak B. Sleep-disordered breathing in pregnancy. Int J Sleep Wakefulness 2008; 1:98-108.
5. Pien GW, Schwab RJ. Sleep disorders during pregnancy. Sleep 2004; 27:1405-1417.
6. Franklin KA, Holmgren PA, Jonsson F, et al. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000; 117:137-141. (Pubitemid 30053632)
7. Izci B, Riha RL, Martin SE, et al. The upper airway in pregnancy and preeclampsia. Am J Respir Crit Care Med 2003; 167:137-140.
8. Yinon D, Lowenstein L, Suraya S, et al. Preeclampsia is associated with sleep-disordered breathing and endothelial dysfunction. Eur Respir J 2006; 27:328-333. (Pubitemid 43180910)
9. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008; 133:496-506. (Pubitemid 351272411)
10. Punjabi NM, Beamer BA. Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med 2009; 179:235-240.
11. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283:1829-1836.
12. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320:479-482. (Pubitemid 30173118)
13. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleepdisordered breathing. Arch Intern Med 2000; 160:2289-2295.
14. O'Connor GT, Caffo B, Newman AB, et al. Prospective study of sleepdisordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009; 179:1159-1164.
15. Phillips CL, Cistulli PA. Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects. Minerva Medica 2006; 97:299-312. (Pubitemid 44687356)
16. Budhiraja R, Parthasarathy S, Quan SF. Endothelial dysfunction in obstructive sleep apnea. J Clin Sleep Med 2007; 3:409-415. (Pubitemid 46984039)
17. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166:159-165. (Pubitemid 34765451)
18. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365:1046-1053. (Pubitemid 40386782)
19. Okun ML, Roberts JM, Marsland AL, Hall M. How disturbed sleep may be a risk factor for adverse pregnancy outcomes. Obstet Gynecol Surv 2009; 64:273-280.
20. Connolly G, Razak AR, Hayanga A, et al. Inspiratory flow limitation during sleep in preeclampsia: comparison with normal pregnant and nonpregnant women. Eur Respir J 2001; 18:672-676. (Pubitemid 33040627)
21. Guilleminault C, Palombini L, Poyares D, et al. Preeclampsia and nasal CPAP: part 1. Early intervention with nasal CPAP in pregnant women with risk-factors for preeclampsia: preliminary findings. Sleep Med 2007; 9:9-14. (Pubitemid 350187606)
22. Izci-Balserak B, Ratcliffe S, PienG. SDB and daytime napping are associated with higher glucose levels in pregnant women. Sleep 2010; 33:A119. (Abstract 0339).
23. Shaw JE, Punjabi NM, Wilding JP, et al. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008; 81:2-12.
24. Arnaud C, Dematteis M, Pepin JL, et al. Obstructive sleep apnea, immunoinflammation, and atherosclerosis. Semin Immunopathol 2009; 31:113-125.
25. Follenius M, Brandenberger G, Bandesapt JJ, et al. Nocturnal cortisol release in relation to sleep structure. Sleep 1992; 15:21-27.
26. Meerlo P, Sgoifo A, Suchecki D. Restricted and disrupted sleep: effects on autonomic function, neuroendocrine stress systems and stress responsivity. Sleep Med Rev 2008; 12:197-210.
27. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003; 7:35-51. (Pubitemid 36188305)
28. Xu J, Long YS, Gozal D, Epstein PN. Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic Biol Med 2009; 46:783-790.
29. Roberts JM, Lain KY. Recent insights into the pathogenesis of preeclampsia. Placenta 2002; 23:359-372.
30. Jerath R, Barnes VA, Fadel HE. Mechanism of development of preeclampsia linking breathing disorders to endothelial dysfunction. Med Hypotheses 2009; 73:163-166.
31. Roberts JM, Hubel CA. Oxidative stress in preeclampsia. Am J Obstet Gynecol 2004; 190:1177-1178.
32. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96:1897-1904.
33. Narkiewicz K, Somers VK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 2003; 177:385-390. (Pubitemid 36337642)
34. Fletcher EC. Effect of episodic hypoxia on sympathetic activity and blood pressure. Respir Physiol 2000; 119:189-197. (Pubitemid 30155574)
35. Moller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-h blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16:274-280. (Pubitemid 36384754)
36. Schobel HP, Fischer T, Heuszer K, et al. Preeclampsia: a state of sympathetic overactivity. N Engl J Med 1996; 335:1480-1485.
37. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005; 112:2660-2667. (Pubitemid 41532603)
38. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004; 27:123-128. (Pubitemid 43906323)
39. Ciftci TU, Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004; 28:87-91. (Pubitemid 39302489)
40. Nacher M, Farre R, Montserrat JM, et al. Biological consequences of oxygen desaturation and respiratory effort in an acute animal model of obstructive sleep apnea (OSA). Sleep Med 2009; 10:892-897.
41. Okun ML, Coussons-Read M, Hall M. Disturbed sleep is associated with increased C-reactive protein in young women. Brain Behav Immun 2009; 23:351-354.
42. Okun ML, Coussons-Read ME. Sleep disruption during pregnancy: how does it influence serum cytokines? J Reprod Immunol 2007; 73:158-165.
43. Okun ML, Hall M, Coussons-Read ME. Sleep disturbances increase interleukin-6 production during pregnancy: implications for pregnancy complications. Reprod Sci 2007; 14:560-567. (Pubitemid 351168786)
44. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82:4196-4200. (Pubitemid 27525539)
45. Bartha JL, Romero-Carmona R, Comino-Delgado R. Inflammatory cytokines in intrauterine growth retardation. Acta Obstet Gynecol Scand 2003; 82:1099-1102. (Pubitemid 37449375)
46. Freeman DJ, McManus F, Brown EA, et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44:708-714. (Pubitemid 39435242)
47. Holcberg G, Huleihel M, Sapir O, et al. Increased production of tumor necrosis factor-alpha TNF-alpha by IUGR human placentae. Eur J Obstet Gynecol Reprod Biol 2001; 94:69-72. (Pubitemid 32008001)
48. Romero R, Espinoza J, Goncalves LF, et al. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 2006; 11:317-326. (Pubitemid 44038705)
49. Wolf M, Sauk J, Shah A, et al. Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care 2004; 27:21-27. (Pubitemid 38196704)
50. Teran E, Escudero C, Moya W, et al. Elevated C-reactive protein and proinflammatory cytokines in Andean women with preeclampsia. Int J Gynaecol Obstet 2001; 75:243-249. (Pubitemid 33122080)
51. Laskowska M, Leszczynska-Gorzelak B, Laskowska K, Oleszczuk J. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus. J Matern Fetal Neonatal Med 2006; 19:347-351. (Pubitemid 43995616)
52. Menon R, Merialdi M, Lombardi SJ, Fortunato SJ. Differences in the placental membrane cytokine response: a possible explanation for the racial disparity in preterm birth. Am J Reprod Immunol 2006; 56:112-118.
53. Larsen JJ, Hansen JM, Olsen NV, et al. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 1997; 504 (Pt 1):241-249.
54. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169:156-162. (Pubitemid 38114528)
55. Szelenyi J, Vizi ES. The catecholamine cytokine balance: interaction between the brain and the immune system. Ann N Y Acad Sci 2007; 1113:311-324. (Pubitemid 350015022)
56. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000; 21:55-89.
57. Sorrells SF, Sapolsky RM. An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 2007; 21:259-272.
58. Soares AF, Guichardant M, Cozzone D, et al. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med 2005; 38:882-889. (Pubitemid 40321080)
59. Hashimoto T, Kihara M, Imai N, et al. Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis. Am J Pathol 2007; 171:1705-1712. (Pubitemid 350158330)
60. Moschen AR, Kaser A, Enrich B, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007; 178:1748-1758. (Pubitemid 46154646)
61. Lam JC, Xu A, Tam S, et al. Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep 2008; 31:1721-1727.
62. Salomon LJ, Benattar C, Audibert F, et al. Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. Am J Obstet Gynecol 2003; 189:1517-1522. (Pubitemid 38056417)
63. Makino S, Handa H, Suzukawa K, et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 2006; 64:12-19.
64. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol 2007; 50:938-948.
65. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354:1435-1439. (Pubitemid 29494756)
66. Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160:521-530. (Pubitemid 39215628)
67. Kaaja RJ, Poyhonen-Alho MK. Insulin resistance and sympathetic overactivity in women. J Hypertens 2006; 24:131-141. (Pubitemid 41818098)
68. Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 2010; 137:95-101.
69. Festa A, D'Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102:42-47. (Pubitemid 30430551)
70. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995; 85:353-356.
71. Facco FL, Grobman WA, Kramer J, et al. Self-reported short sleep duration and frequent snoring in pregnancy: impact on glucose metabolism. Am J Obstet Gynecol 2010; 203:142.e1-142.e5.
72. Qiu C, Enquobahrie D, Frederick IO, et al. Glucose intolerance and gestational diabetes risk in relation to sleep duration and snoring during pregnancy: a pilot study. BMC Womens Health 2010; 10:17.
73. Bourjeily G, Raker CA, Chalhoub M, Miller MA. Sleep disordered breathing symptoms in pregnancy and adverse pregnancy and fetal outcomes. Eur Respir J 2010. [Epub ahead of print]
74. Edwards N, Blyton D, Sullivan C. Fetal movement is suppressed during maternal sleep in preeclampsia. Sleep 2007; 30:A321. (Abstract 0939).
75. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007; 30 (Suppl 2):S251-S260. (Pubitemid 47036434)
76. Retnakaran R, Shah BR. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 2009; 181:371-376.
77. Herring SJ, Oken E, Rifas-Shiman SL, et al. Weight gain in pregnancy and risk of maternal hyperglycemia. Am J Obstet Gynecol 2009; 201:61.e1-61.e7.
78. Tovar A, Must A, Bermudez OI, et al. The impact of gestational weight gain and diet on abnormal glucose tolerance during pregnancy in Hispanic women. Matern Child Health J 2009; 13:520-530.
79. Xiong X, Saunders LD, Wang FL, Demianczuk NN. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet 2001; 75:221-228. (Pubitemid 33122077)
80. Dang K, Homko C, Reece EA. Factors associated with fetal macrosomia in offspring of gestational diabetic women. J Matern Fetal Med 2000; 9:114-117. (Pubitemid 30368450)
81. HAPO Study Cooperative Research Group. Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358:1991-2002.
82. Ayas NT, White DP, Al-Delaimy WK, et al. A prospective study of selfreported sleep duration and incident diabetes in women. Diabetes Care 2003; 26:380-384. (Pubitemid 36929059)
83. Renko AK, Hiltunen L, Laakso M, et al. The relationship of glucose tolerance to sleep disorders and daytime sleepiness. Diabetes Res Clin Pract 2005; 67:84-91. (Pubitemid 40037734)
84. Yaggi HK, Araujo AB, McKinlay JB, et al. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006; 29:657-661. (Pubitemid 44115369)
85. Carpagnano GF, Karitonov SA, Resta O, et al. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 2002; 122:1162-1167. (Pubitemid 35339525)
86. Coughlan MT, Vervaart PP, Permezel M, et al. Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 2004; 25:78-84. (Pubitemid 38100769)
87. Coughlan MT, Permezel M, Georgiou HM, Rice GE. Repression of oxidant-induced nuclear factor-kappaB activity mediates placental cytokine responses in gestational diabetes. J Clin Endocrinol Metab 2004; 89:3585-3594. (Pubitemid 38951938)
88. Lappas M, Permezel M, Rice GE. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89:5627-5633. (Pubitemid 39518451)
89. Retnakaran R, Hanley AJ, Raif N, et al. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004; 27:799-800. (Pubitemid 38280554)
90. Williams MA, Qiu C, Muy-Rivera M, et al. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89:2306-2311. (Pubitemid 38619868)
91. Wolf M, Sandler L, Hsu K, et al. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003; 26:819-824. (Pubitemid 36929349)
92. Qiu C, Sorensen TK, Luthy DA, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol 2004; 18:377-384. (Pubitemid 39304358)
93. Ategbo JM, Grissa O, Yessoufou A, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006; 91:4137-4143. (Pubitemid 44536897)
94. Zhang J, Zeisler J, Hatch MC, Berkowitz G. Epidemiology of pregnancyinduced hypertension. Epidemiologic Reviews 1997; 19:218-232.
95. Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet 2005; 365:785-799.
96. Champagne K, Schwartzman K, Opatrny L, et al. Obstructive sleep apnoea and its association with gestational hypertension. Eur Respir J 2009; 33:559-565.
97. Ursavas A, Karadag M, Rodoplu E, et al. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration 2007; 74:525-532. (Pubitemid 47206882)
98. Poyares D, Guilleminault C, Hachul H, et al. Preeclampsia and nasal CPAP: part 2. Hypertension during pregnancy, chronic snoring, and early nasal CPAP intervention. Sleep Med 2007; 9:15-21. (Pubitemid 350187605)
99. Cudihy D, Lee RV. The pathophysiology of preeclampsia: current clinical concepts. J Obstet Gynaecol 2009; 29:576-582.
100. Zhang C, Williams MA, Sanchez SE, et al. Plasma concentrations of carotenoids, retinol, and tocopherols in preeclamptic and normotensive pregnant women. Am J Epidemiol 2001; 153:572-580. (Pubitemid 32221712)
101. Grabska-Kobylecka I, Kobylecki A, Bialasiewicz P, et al. No evidence of enhanced oxidant production in blood obtained from patients with obstructive sleep apnea. J Negat Results Biomed 2008; 7:10.
102. Palan PR, Mikhail MS, Romney SL. Placental and serum levels of carotenoids in preeclampsia. Obstet Gynecol 2001; 98:459-462.
103. Lavie L. Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach. Neurol Clin 2005; 23:1059-1075. (Pubitemid 41503065)
104. Ouyang YQ, Li SJ, Zhang Q, et al. Interactions between inflammatory and oxidative stress in preeclampsia. Hypertens Pregnancy 2009; 28: 56-62.
105. Salamonsen LA, Hannan NJ, Dimitriadis E. Cytokines and chemokines during human embryo implantation: roles in implantation and early placentation. Semin Reprod Med 2007; 25:437-444. (Pubitemid 350058430)
106. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93:1049-1059. (Pubitemid 16004866)
107. Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993; 168:585-591. (Pubitemid 23069118)
108. Edwards N, Blyton DM, Kirjavainen T, et al. Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia. Am J Respir Crit Care Med 2000; 162:252-257. (Pubitemid 30469829)
109. Blyton DM, Sullivan CE, Edwards N. Reduced nocturnal cardiac output associated with preeclampsia is minimized with the use of nocturnal nasal CPAP. Sleep 2004; 27:79-84. (Pubitemid 43906316)
110. Edwards N, Blyton DM, Kirjavainen TT, Sullivan CE. Hemodynamic responses to obstructive respiratory events during sleep are augmented in women with preeclampsia. Am J Hypertens 2001; 14:1090-1095. (Pubitemid 33033106)
111. Blyton DM, Sullivan CE, Edwards N. Lactation is associated with an increase in slow-wave sleep in women. J Sleep Res 2002; 11:297-303. (Pubitemid 35478073)
112. Klebanoff MA, Shiono PH, Rhoads GG. Outcomes of pregnancy in a national sample of resident physicians. N Engl J Med 1990; 323:1040-1045.
113. Louis JM, Auckley D, Sokol RJ, et al. Maternal and neonatal morbidities associated with obstructive sleep apnea complicating pregnancy. Am J Obstet Gynecol 2010; 202:261.e1-261.e5.
114. Roush SF, Bell L. Obstructive sleep apnea in pregnancy. J Am Board Fam Pract 2004; 17:292-294.
115. Sahin FK, Koken G, Cosar E, et al. Obstructive sleep apnea in pregnancy and fetal outcome. Int J Gynaecol Obstet 2008; 100:141-146.
116. Tremblay K, Bullough A, O'Brien L. Habitual snoring is not associated with lower infant birth weight. Sleep 2009; 32:A334. (Abstract 1025).
117. Hedman C, Pohjasvaara T, Tolonen U, et al. Effects of pregnancy on mothers' sleep. Sleep Medicine 2002; 3:37-42. (Pubitemid 34177184)
118. Gozal D, Reeves SR, Row BW, et al. Respiratory effects of gestational intermittent hypoxia in the developing rat. Am J Respir Crit Care Med 2003; 167:1540-1547. (Pubitemid 37363365)
119. Hastie SJ, Prowse K, Perks WH, et al. Obstructive sleep apnoea during pregnancy requiring tracheostomy. Aust N Z J Obstet Gynaecol 1989; 29:365-367. (Pubitemid 19259591)
120. Leung PL, Hui DS, Leung TN, et al. Sleep disturbances in Chinese pregnant women. BJOG 2005; 112:1568-1571. (Pubitemid 43961248)